Effects of Intensive Blood Pressure Control in Patients With Frailty
JACC · 2026-01 · 87 (1) · 4-16
DOI: 10.1016/j.jacc.2025.08.092 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift JACC, 2026-01. Verfasst von Shitian Li und 24 weiteren Autor:innen. Beteiligte Einrichtung: National Clinical Research Center for Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, Chinese Academy of Med…. Hauptthemen laut MEDLINE: Frailty, Hypertension, Antihypertensive Agents, Blood Pressure. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Chinese Academy of Medical Sciences and Peking Union Medical College Fuwai Hospital, Ministry of Science and Technology of the People's Republic of China.
Themen: Gerontologische Pflege
Abstract (Originalsprache)
BACKGROUND: Evidence regarding the benefits and harms of intensive blood pressure (BP) control in patients with higher degrees of frailty is limited. OBJECTIVES: We aimed to characterize the benefit-harm profile of intensive BP control by frailty status in the ESPRIT trial. METHODS: In this post hoc analysis of the ESPRIT trial, we categorized participants into nonfrail, moderately frail, and severely frail according to their baseline frailty index (FI), which was calculated by the Rockwood cumulative deficit approach. We examined heterogeneity in the effect of intensive BP-lowering treatment on major adverse cardiovascular events (MACE) (a composite of myocardial infarction, hospitalization for heart failure, stroke, or death from cardiovascular diseases), all-cause death, and safety outcomes (kidney outcomes, and other serious adverse events of special interest [hypotension, syncope, electrolyte abnormality, injurious fall, or acute kidney injury]). RESULTS: We included 11,255 participants whose average age was 64.6 ± 7.1 years. Of the total participants, 4,366 (38.8%) were nonfrail (FI ≤0.210), 5,257 (46.7%) were moderately frail (FI 0.211-0.310), and 1,632 (14.5%) were severely frail (FI ≥0.311). Compared with nonfrail, moderately frail (HR: 1.32; 95% CI: 1.24-1.41) and severely frail (HR: 1.68; 95% CI: 1.54-1.84) participants were associated with a higher risk of serious adverse events. The effects of intensive treatment on MACE did not vary significantly by level of frailty (nonfrail: risk ratio [RR]: 0.84; 95% CI: 0.65-1.08; moderately frail: RR: 0.83; 95% CI: 0.70-0.99; severely frail: RR: 0.86; 95% CI: 0.69-1.08; Pinteraction = 0.67). Effects on all-cause death showed a similar pattern. Greater absolute risk reductions in MACE, cardiovascular death, and all-cause death were observed with increasing frailty, but the interactions were not significant. The effects of intensive treatment were also consistent across the spectrum of continuous FI. None of the safety outcomes differed by frailty status. CONCLUSIONS: Hypertensive patients with high cardiovascular risk benefit from the treatment strategy of targeting systolic BP
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Clinical Research Center for Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, National Center for Ca…
- Kaifeng Central Hospital, Kaifeng, China.
- Maanshan General Hospital Ranger-Duree Healthcare, Maanshan, China.
- The First People's Hospital of Shenyang, Shenyang, China.
- Rushan People's Hospital, Rushan, China.
- Jiaojiang District Baiyun Street Community Health Service Center, Taizhou, China.
Förderung
- Chinese Academy of Medical Sciences and Peking Union Medical College Fuwai Hospital
- Ministry of Science and Technology of the People's Republic of China
Zitieren
APA
Li, S., Peng, Y., Li, Y., Sun, Y., Yan, X., Zhang, L., Liu, J., Zhao, L., Liu, J., Qian, J., Zhai, N., Dong, L., Ruan, J., Zhang, P., Wei, X., Liu, Y., Ma, Q., Huang, W., Zhang, Q., …, & ESPRIT Investigators (2026). Effects of Intensive Blood Pressure Control in Patients With Frailty. JACC, 87(1), 4-16. https://doi.org/10.1016/j.jacc.2025.08.092
Vancouver
Li S, Peng Y, Li Y, Sun Y, Yan X, Zhang L, et al. Effects of Intensive Blood Pressure Control in Patients With Frailty. JACC. 2026;87(1):4-16. doi:10.1016/j.jacc.2025.08.092
BibTeX
@article{Li2026,
author = {Li, Shitian and Peng, Yue and Li, Yan and Sun, Ying and Yan, Xiaofang and Zhang, Liping and Liu, Jiangling and Zhao, Lingshan and Liu, Jieyun and Qian, Jun and Zhai, Na and Dong, Lei and Ruan, Jiahui and Zhang, Ping and Wei, Xiqing and Liu, Yong and Ma, Qiaojuan and Huang, Weijun and Zhang, Qiang and An, Chun and Liu, Jiamin and Sheng, Li and Zhang, Haibo and Li, Jing and ESPRIT Investigators, ESPRIT Investigators},
title = {Effects of Intensive Blood Pressure Control in Patients With Frailty},
journal = {JACC},
year = {2026},
volume = {87},
number = {1},
pages = {4--16},
doi = {10.1016/j.jacc.2025.08.092}
}
EUVIMED